Belgian Pharma Stock News

UCB previously announced that it would receive capital support from the UK government’s Life Sciences Innovative Manufacturing Fund as part of a joint investment of around £500 million to expand its R&D activities at the Windlesham, Surrey research hub. This funding underscores how the UK’s research infrastructure has become integral to UCB’s discovery engine, with several of its treatments originating from UK-based laboratories. We will now consider how this UK government-backed R&D...

AB InBev has secured an exclusive beer and cider partnership with Live Nation in the UK. The agreement connects AB InBev brands to major music festivals and venues, targeting millions of attendees. The partnership focuses on immersive on site experiences and expanded visibility for the brewer's portfolio. For investors watching Anheuser-Busch InBev, ticker ENXTBR:ABI, this Live Nation deal links a global brewer with one of the UK's largest live entertainment platforms. With the current...

Argenx (ENXTBR:ARGX) is back in focus after the U.S. Food and Drug Administration accepted a priority review for a supplemental Biologics License Application for VYVGART in seronegative generalized myasthenia gravis. See our latest analysis for argenx. The FDA priority review has arrived after a year where argenx’s share price has been relatively muted in the short term, with a 30 day share price return of 2.45% decline and year to date share price return of 3.15% decline. However, the 1 year...

DEME has taken delivery of its second new wind turbine installation vessel, Norse Energi, from CIMC Raffles Shipyard, a purpose-built ship designed to handle the next generation of large-scale offshore wind turbines with advanced lifting, loading, and sustainability features. By pairing Norse Energi with its sister vessel Norse Wind, DEME is expanding a specialized fleet that could enhance its role in complex offshore wind installation projects worldwide. We will now examine how this...

AB InBev’s Live Nation deal puts its brands at UK music forefront Anheuser-Busch InBev (ENXTBR:ABI) has been named exclusive beer and cider partner for Live Nation’s UK festivals and venues, connecting Budweiser, Corona, Stella Artois and others with millions of concert and festival goers. See our latest analysis for Anheuser-Busch InBev. The Live Nation agreement lands as Anheuser-Busch InBev’s recent 30-day share price return of 8.28% and 90-day share price return of 11.60% contrast with a...

Earlier in 2026, Belgium-based insurer Ageas raised its full-year guidance after China Taiping Insurance Holding’s updated tax treatment under IFRS 17/9 implied a positive one-off impact via their Taiping Life joint venture. This combination of stronger guidance and a tax-related uplift in China underscores management’s confidence in both core insurance operations and cross-border partnerships. We’ll now explore how the upgraded guidance, underpinned by the one-off tax benefit in China,...

KBC Bank has launched Bitcoin and Ethereum trading for retail customers via its Bolero investment platform, becoming Belgium’s first bank to offer crypto trading under the EU’s Markets in Crypto-Assets (MiCA) regulation. The move positions KBC as an early adopter of regulated digital asset services in European banking, giving clients crypto exposure without allowing transfers to external wallets. We’ll now examine how this MiCA-compliant crypto launch shapes KBC Group’s investment narrative...

Viohalco (EBR:VIO) has had a great run on the share market with its stock up by a significant 52% over the last three...

In January 2026, Nokia announced that Proximus had selected its cloud-native Converged Charging and voice core solutions to modernize Proximus’s online charging system and migrate all fixed and mobile customers, along with more than 1,000 products, onto a unified platform. This large-scale overhaul positions Proximus to support more automated networks and introduce new 5G-related charging models across its entire customer base. Next, we examine how this cloud-native charging migration with...

argenx SE recently announced that the U.S. FDA has accepted for priority review a supplemental Biologics License Application for VYVGART to treat adults with acetylcholine receptor antibody seronegative generalized myasthenia gravis, supported by the Phase 3 ADAPT SERON study that met its primary endpoint. This filing, which covers all three seronegative gMG subtypes (MuSK+, LRP4+, and triple seronegative), highlights an effort to expand treatment options for a group of patients with fewer...

Key Insights Given the large stake in the stock by institutions, Azelis Group's stock price might be vulnerable to...

Offshore wind vessel delivery and what it might mean for DEME Group shares DEME Group (ENXTBR:DEME) has taken delivery of Norse Energi, its second new wind turbine installation vessel, expanding its ability to handle next generation offshore wind projects and putting fresh attention on the stock. See our latest analysis for DEME Group. The delivery of Norse Energi comes at a time when DEME Group’s share price has a 30 day share price return of 11.46% and a 90 day share price return of 14.92%,...

As the European markets show resilience with the STOXX Europe 600 Index rising by 0.77% amid strong economic data and mixed earnings results, investors are increasingly looking for stability in their portfolios. In this environment, dividend stocks can offer a reliable income stream and potential for capital appreciation, making them an attractive option for those seeking to enhance their investment strategies.

What recent performance says about Solvay Solvay (ENXTBR:SOLB) has drawn investor attention after a mixed run in its share price, with a 1.7% gain over the past day contrasting with weaker returns over the past month and past 3 months. That short term rebound comes after a 6.5% decline over the past month and a 10.3% drop over the past 3 months, while the 1 year total return is down 10.6% and the year to date performance shows a 7.8% decline. See our latest analysis for Solvay. The €25.22...

Wondering if SCR-Sibelco at €4,800 is offering value right now, or if the price already reflects what the market knows about the business. The share price is flat over the last week, with a 5.9% decline over 30 days, an 11.9% decline year to date, a 3.4% gain over 1 year, and a 2.1% and 10.2% decline over 3 and 5 years respectively. These figures may shape how you think about both risk and potential upside. Recent coverage of SCR-Sibelco has focused on providing evergreen context for the...

As the European markets navigate a landscape of resilient economic data and mixed earnings results, the pan-European STOXX Europe 600 Index has shown positive momentum, ending 0.77% higher recently. In this environment, growth companies with high insider ownership can be particularly appealing due to their potential for strong alignment between management and shareholder interests.

Why the latest update on ageas (ENXTBR:AGS) matters Ageas (ENXTBR:AGS) raised its 2025 Net Operating Result guidance to a range of €1.6b to €1.65b, after new corporate income tax treatments under IFRS17/9 benefited its Chinese joint venture Taiping Life. See our latest analysis for ageas. The guidance upgrade arrives after a period where momentum has been relatively steady, with a 90 day share price return of 4.55% and a 1 year total shareholder return of 27.91% building on multi year...

In January 2026, Live Nation announced AB InBev as the exclusive beer and cider partner across major UK festivals, venues, and outdoor shows, putting brands like Budweiser, Corona, San Miguel and Stella Artois at the centre of the live music scene for fans of legal drinking age. The partnership deepens a long-running global relationship between the brewer and the live entertainment group, giving AB InBev extensive on-the-ground and digital exposure at more than 20 festivals and Academy Music...

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'll want to see a proven...

As the European markets navigate a landscape of resilient economic data and mixed earnings results, investors are keeping a close eye on opportunities that offer stability and potential income. In this context, dividend stocks stand out as an attractive option for those seeking to capitalize on consistent returns, particularly in times of market uncertainty.

With a median price-to-sales (or "P/S") ratio of close to 0.9x in the Building industry in Belgium, you could be...

As the European markets experience a mix of modest gains and losses, with indices like Germany's DAX and Italy's FTSE MIB showing resilience against a backdrop of economic recovery, investors are increasingly on the lookout for opportunities that may be undervalued. In this context, identifying stocks trading below their intrinsic value can offer potential avenues for growth, especially when supported by strong fundamentals and favorable market conditions.

As the European markets show resilience with the STOXX Europe 600 Index ending higher, supported by robust economic data and earnings results, investors are increasingly considering dividend stocks to enhance their portfolios. In this context, selecting stocks with a strong track record of consistent dividend payouts can be an effective strategy for those looking to balance growth and income in today's dynamic market environment.

As an investor its worth striving to ensure your overall portfolio beats the market average. But if you try your hand...